US Patent 7435818 Crystal forms of irinotecan hydrochloride

Patent 7435818 was granted and assigned to ScinoPharm Taiwan on October, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

ScinoPharm Taiwan

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74358180

Patent Inventor Names

Shu-Ping Chen0

Piin-Jye Harn0

Date of Patent

October 14, 2008

Patent Application Number

115233670

Date Filed

September 19, 2006

Patent Primary Examiner

‌

Charanjit S. Aulakh

Patent abstract

The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.